Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Upadacitinib 30mg Dose
DRUG
2 trials
Sponsors
AbbVie
, University of North Carolina, Chapel Hill
Conditions
Atopic Dermatitis
EoE
Eosinophilic Esophagitis
Eosinophilic Esophagitis (EoE)
Phase 2
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Not yet recruiting
NCT07588568
University of North Carolina, Chapel Hill
EoE, Eosinophilic Esophagitis, Eosinophilic Esophagitis (EoE)
Start: 2026-10-01
End: 2030-06-01
Target: 52
Updated: 2026-08-21
Phase 3
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
Recruiting
NCT06389136
AbbVie
Atopic Dermatitis
Start: 2024-06-14
End: 2027-03-01
Target: 200
Updated: 2026-07-06